To view the full citation, click here.
Strategies for the Follow‐Up of Positive Results in the In Vitro Genotoxicity Assays—An International Collaborative Initiative
Environmental and Molecular Mutagenesis, 2011
Open access, peer-reviewed publications ensure that knowledge is a public good. HESI believes that accessible research is critical for equitable engagement, diverse collaboration, and increased interdisciplinary conversation. We strive to achieve open access on all publications, and more than 200 publications from HESI programs have been published in the last decade.
Environmental and Molecular Mutagenesis, 2011
To view the full citation, click here.
Journal of Immunotoxicology, 2020
Currently, there is a multitude of CD3 bispecifics with different molecular designs and binding properties in preclinical and clinical development for the treatment of liquid or solid tumors. The key safety concerns with CD3 bispecifics are excessive release of cytokines, which may translate to potentially life-threating ...
Journal of Immunotoxicology, 2012
Epstein-Barr virus (EBV)-associated lymphomas are a known risk for immunosuppressed individuals.
Birth Defects Research Part B: Developmental and Reproductive Toxicology, 2013
The Developmental and Reproductive Toxicity Technical Committee of the Health and Environmental Sciences Institute hosted a working consortium of companies to evaluate a new commercially available analytic assay for Inhibin B in rat serum or plasma.
Journal of Immunotoxicology, 2012
While immunotoxicology evaluations are often conducted in either rodents or non-human primates, findings in standard toxicology studies may trigger additional investigations in dogs.
Journal of Toxicology: Cutaneous and Ocular Toxicology, 1996
Products in commerce, whether drugs, cosmetics, home and automobile care products, or bulk chemicals, are subject to a variety of tests to determine whether the ingredients and products have any potential adverse health effects.
hesi@hesiglobal.org
Phone: +1-202-659-8404
Fax: +1-202-659-3859
740 15th Street NW, Suite 600
Washington, DC 20005
Sign up for our monthly e-newsletter.